HESTER BIOSCIENCES
Back to Income Statement
|
HESTER BIOSCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹27 Cr | ₹19 Cr | ₹27 Cr | ₹39 Cr | ₹34 Cr |
What is the latest Consolidated Net Profit of HESTER BIOSCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹27 Cr |
| Mar2024 | ₹19 Cr |
| Mar2023 | ₹27 Cr |
| Mar2022 | ₹39 Cr |
| Mar2021 | ₹34 Cr |
How is Consolidated Net Profit of HESTER BIOSCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹27 Cr | 45.52 | |
| Mar2024 | ₹19 Cr | -29.06 | |
| Mar2023 | ₹27 Cr | -32.28 | |
| Mar2022 | ₹39 Cr | 14.20 | |
| Mar2021 | ₹34 Cr | - | |
Compare Consolidated Net Profit of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹1,240.8 Cr | -5.5% | -8.7% | -32.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,541.0 Cr | -3.6% | -6.8% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,031.0 Cr | -5.4% | -2.4% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,451.0 Cr | 3.6% | 8.5% | 23.5% | Stock Analytics | |
| CIPLA | ₹112,377.0 Cr | -5.1% | -7.1% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,355.5 Cr | -4.1% | -8.3% | -12.1% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | -5.5% |
-8.7% |
-32.7% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses